Join the PIK3CA-Related Overgrowth Spectrum group to help and get support from people like you.
PIK3CA-Related Overgrowth Spectrum News
Related terms: PROS
FDA Approves Vijoice (alpelisib) for the Treatment of PIK3CA-Related Overgrowth Spectrum (PROS)
Vijoice is first approved treatment to specifically address the root cause of PROS conditions in select patients 2 years of age and older1 PROS is a spectrum of rare conditions and is...